Results 171 to 180 of about 49,377 (194)
Some of the next articles are maybe not open access.
Independent Nurse, 2005
From April, all 65s and over will be eligible for pneumococcal vaccination.
Melanie Milburn Rgn, DipN
openaire +2 more sources
From April, all 65s and over will be eligible for pneumococcal vaccination.
Melanie Milburn Rgn, DipN
openaire +2 more sources
Models of pneumococcal disease
Drug Discovery Today: Disease Models, 2006Streptococcus pneumoniae is a leading cause of invasive Gram-positive disease. Infection progresses from the nasopharynx to otitis, pneumonia, bacteremia, sepsis and meningitis. Steadily increasing multidrug resistance has forced testing of new antibiotics and vaccines, as well as new adjunctive therapies based on insights into pathogenesis.
Elaine Tuomanen, Carlos J. Orihuela
openaire +2 more sources
Influenza and pneumococcal disease in the community
Nursing Standard, 2003The authors discuss the aetiology, diagnosis and prevention of influenza and pneumococcal disease, identifying who should be vaccinated and those who are at risk. Useful information on how to plan an immunisation campaign is also outlined.
Cate Riley, Steven Riley
openaire +3 more sources
An Epidemiologic Approach to Pneumococcal Disease
Clinical Infectious Diseases, 1981In many countries of the developing world, pneumonia remains a leading cause of morbidity and premature mortality. In their quest for effective control measures not dependent on the socioeconomic changes in Western societies that have paralleled a reduction in mortality from pneumonia, these poorer countries are looking towards modern antibiotic ...
Robert M Douglas, Ian Riley
openaire +3 more sources
The future of pneumococcal disease prevention
Vaccine, 2011Pneumococcal disease (PD) is the leading cause of vaccine preventable deaths in children
Gail L. Rodgers +2 more
openaire +3 more sources
Invasive Pneumococcal and Meningococcal Disease
Infectious Disease Clinics of North America, 2019This review focuses on current knowledge of the epidemiology, prevention, and treatment of invasive pneumococcal (IPD) and meningococcal disease (IMD). IPD decreased significantly with the introduction of effective conjugate vaccines but is on the rise again.
Deirdre B. Fitzgerald, Grant W. Waterer
openaire +2 more sources
Prevention and management of pneumococcal disease
Nursing Standard, 2001Pneumococcal pneumonia is associated with high mortality in immunocompromised and older people. The authors discuss the role nurses have in increasing awareness of vaccination and use of preventive interventions to target at-risk patients.
Laila King, Jackie Burns
openaire +3 more sources
The History of Pneumococcal Disease [PDF]
, 2014 This chapter reviews some of the major events in the history of Streptococcus pneumoniae—events that have led to our modern understanding of the pathogenesis, diagnosis, treatment, and prevention of pneumococcal disease. Manifestations of primary infection involved the respiratory tract, including pneumonia, acute purulent tracheobronchitis, otitis ...
Barry M. Gray, Daniel M. Musher
openaire +1 more source
The Prevention of Pneumococcal Disease in Children
New England Journal of Medicine, 2001Streptococcus pneumoniae accounts for half of all cases of acute otitis media, and it remains a major cause of illness and death in children. The strategies for prevention now include the use of a conjugate vaccine to induce immunity in infants, who are the group at highest risk.
openaire +3 more sources
Impact of pneumococcal vaccines on invasive pneumococcal disease in Taiwan
European Journal of Clinical Microbiology & Infectious Diseases, 2010In Taiwan, the 23-valent pneumococcal polysaccharide vaccine (PPV23) and the 7-valent pneumococcal conjugate vaccine (PCV7) have been available since January 2001 and October 2005, respectively. A hospital-based surveillance of invasive pneumococcal disease (IPD) in a medical center was conducted from 2000 to 2008 to evaluate the epidemiologic changes ...
Che-Kim Tan +7 more
openaire +2 more sources